Chicago, Illinois – NXT Capital announced that it has provided a senior secured credit facility to refinance WellSpring Pharmaceutical Corporation. WellSpring is a portfolio company of Sentinel Capital Partners and Ancor Capital Partners.
The transaction included WellSpring’s add-on acquisition of FDS, a personal care brand that specializes in feminine hygiene products.
NXT Capital was the Joint Lead Arranger, Joint Bookrunner and Administrative Agent for this transaction.
Sentinel Capital Partners is a leading lower middle-market private equity firms. The firm invests in management buyouts, acquisitions of family businesses, corporate divestitures, industry consolidations and going-private transactions in the United States and Canada. Based in New York City, Sentinel has approximately $2.6 billion of capital under management.
Ancor Capital Partners is an operations-oriented private equity firm focused on lower middle-market manufacturing and distribution companies. Founded in 1994, Ancor is located in Fort Worth, Texas. The firm’s track record includes more than 37 acquisitions in health care, consumer and other industries.
WellSpring Pharmaceutical develops, manufactures and markets specialty prescription and over-the counter brands for U.S. and Canadian markets. Headquartered in Sarasota, Florida, WellSpring also offers pharmaceutical contract manufacturing services to companies across North America and Europe.